Weekly Medical Grand Rounds - Archives

2019-2020

June 15, 2020

A RETROSPECTIVE END OF LIFE STUDY OF PATIENTS WITH HEMATOLOGIC MALIGNANCIES AND THE IMPORTANCE OF END OF LIFE DISCUSSION IN SERIOUS ILLNESS
Victoria Korsos
PGY-5 Hematology Resident
McGill University
&
Chantal Cassis MD, MEd, FRCPC
McGill Hematology Program Director
Assistant Professor, Department of Medicine, McGill University
Staff Member, Division of Hematology, Jewish General Hospital
Educational Objectives:
1. Describe the demographics and trajectory of hematology patients at the end of life (EOL).
2.  Describe how McGill-affiliated hospitals performed on previously validated EOL quality indicators
3. Describe how physician goals of therapy, level of intervention discussions and palliative care involvement, impacted performance on the EOL quality indicators
Contact Person: Hans Knecht, MD, Chief, Division of Hematology, Tel 514-340-8222 ext. 28799.

June 8, 2020

Join Zoom Meeting: https://mcgill.zoom.us/j/97454166498, Meeting ID: 974 5416 6498 (No password)
One tap mobile: +16473744685, 97454166498# Canada, +1647558058, 97454166498# Canada
Dial by your location: +1 647 374 4685 Canada, +1 647 558 0588 Canada, +1 778 907 2071 Canada, +1 438 809 7799 Canada,  +1 587 328 1099 Canada, Meeting ID: 974 5416 6498
Find your local number:  https://mcgill.zoom.us/u/aetRjykXJm

ZOOM COMBINED JGH-MUHC MEDICAL GRAND ROUNDS

TRIBUTE TO DR. SUSAN SOLYMOSS
Molly Warner, MD

COVID-19 ASSOCIATED COAGULOPATHY AND THROMBOSIS AND THE CLINICAL IMPLICATIONS 
Véronique Naessens, MD
Assistant Professor, Department of Medicine, McGill University
Division of Hematology, MUHC
Vicky Tagalakis, MD MSc
Associate Professor of Medicine
Director, Division of General Internal Medicine
Division of Internal Medicine, and Centre for Clinical Epidemiology of the Lady Davis Institute for Medical Research
Susan Kahn, MD. MSc
Canada Research Chair
Professor of Medicine, McGill University
Director, JGH Centre of Excellence in Thrombosis and Anticoagulation Care (CETAC)
Educational Objectives:
1. To understand the coagulation changes observed in patients with COVID-19 and associated implications
2. To learn of unique COVID-19 changes in lung vasculature 
3. To understand the importance of thromboprophylaxis in COVID-19 patients and when to intensify anticoagulation
Contact Person: Vicky Tagalakis, MD, MSc, Division of Internal Medicine, Tel. 514-340-7596.

June 1, 2020

COMMUNITY-ACQUIRED PNEUMONIA: SO COMMON BUT SO COMPLICATED IN 2020?
Karl Weiss, MD, MSc, FRCPC 
Professor of Medicine, Department of Medicine, McGill University
Chief, Division of Infectious Diseases, Jewish General Hospital
President of the Association of Infectious Diseases and Microbiology Physicians of Quebec
Educational Objectives:
1. Discuss the value and indication of laboratory tests and imaging for the diagnosis of CAP
2. Discuss the empirical antibiotic regimens in the treatment of CAP in different settings
3. Discuss the value of immunization in the prevention of community-acquired pneumonia
Contact Person: Karl Weiss, MD, Chief, Division of Infectious Diseases, Tel. 514-340-8222 ext. 28294.

May 25, 2020

CANCELLED - ZOOM COMBINED JGH-MUHC MEDICAL GRAND ROUNDS

May 18, 2020

No Rounds - National Patriot Day / Victoria Day

May 11, 2020

COVID AND KIDNEYS
Daniel Blum, MD
Assistant Professor of Medicine, McGill University
Staff Member, Division of Nephrology, Jewish General Hospital
Educational Objectives:
1. Hypertension and the role of the Renin-Angiotensin system in COVID infection
2. Overview of COVID nephropathy and its associated outcomes
3. Review of outcomes in infected dialysis recipients worldwide
4. Preventing an outbreak in the HD unit at the JGH
Contact Person: Mark Lipman, MD, Chief, Division of Nephrology, Tel. 514-340-8229.

May 4, 2020

Osteogenesis Imperfecta-a Window into Genetic Complexity 
David Rosenblatt, MD
Holder, Dodd Q. Chu and Family Chair in Medical Genetics
Professor, Departments of Human Genetics, Medicine, Pediatrics, and Biology
McGill University
Division of Medical Genetics, Department of Specialized Medicine
Jewish General Hospital
Educational Objectives:
1. To understand how thinking about modes of inheritance in lethal osteogenesis imperfecta has evolved
2. To appreciate the value of preserving biological samples from patients
Contact Person: David Rosenblatt, MD, Division of Medical Genetics, Department of Specialized Medicine, Tel. 514-340-8222 ext. 23428.

April 27, 2020

ZOOM COMBINED JGH-MUHC MEDICAL GRAND ROUNDS

12:30- 1:30 PM

PALLIATIVE CARE IN THE TIME OF COVID
Elizabeth MacNamara, MD
Chief, Division of Medical Biochemistry, Jewish General Hospital (JGH) Department of Medicine
Associate Professor of Medicine, McGill University
Tamara Ibrahim, MDCM, CCFP
Division of Palliative Care, JGH and Secondary Care, McGill University Health Centre (MUHC)
Assistant Professor of Family Medicine, McGill University
Philippe-Luc Michel, MD
Division of Palliative Care, JGH
Assistant Professor of Medicine, McGill University
Educational Objectives:
1. Understanding how COVID 19 has changed our approach to end of life care
2. Learning how to use specially developed tools to use on COVID floors for treatment of symptoms and end of life care
3. The importance of involving the families of COVID positive patients
Contact Person: Elizabeth MacNamara, MD, Chief, Division of Medical Biochemistry, Tel. 514-340-8222 x 25091.

April 20, 2020 - Cancelled

Osteogenesis Imperfecta-a Window into Genetic Complexity

David Rosenblatt, MD
Holder, Dodd Q. Chu and Family Chair in Medical Genetics
Professor, Departments of Human Genetics, Medicine, Pediatrics, and Biology
McGill University
Division of Medical Genetics, Department of Specialized Medicine
Jewish General Hospital

Educational Objectives:
1. To understand how thinking about modes of inheritance in lethal osteogenesis imperfecta has evolved
2. To appreciate the value of preserving biological samples from patients

Contact Person: David Rosenblatt, MD, Division of Medical Genetics, Department of Specialized Medicine, Tel. 514-340-8222 ext. 23428.

April 6, 2020

Change in time: 12:55 - 14:00 PM

APPROACH TO THE ACUTELY ILL COVID-19 PATIENT

Kamy Apkarian MDCM, CCFP-EM
Assistant professor, Department of Emergency Medicine, McGill University
Attending Staff, JGH Emergency Department
Member, JGH Emergency Medicine Simulation Tea

Haran Balendra, MDCM, CCFP-EM
Assistant Professor, Department of Emergency Medicine, McGill University
Attending Staff, JGH Emergency Department
Member, JGH Emergency Medicine Simulation Team

Errol Stern MDCM, FRCP, FACEP, CHSE
Associate Professor, Department of Emergency Medicine, McGill University
Attending Staff, JGH Emergency Department
Director, JGH Emergency Medicine Simulation Program

Educational Objectives:

  1. Appreciate the presentation of the silent hypoxic COVID patient
  2. Understand the escalating steps in managing the hypoxic COVID patient
  3. Learn the unique safety approach for Health Care Provider (HCP) involved in a Code Blue of COVID patient
  4. Understand the importance of Crisis Resource Management and debriefing in the care of acutely ill patients

Contact Person: Errol Stern, MDCM, JGH Emergency Department, tel. 514-340-8222 ext. 25568.

*March 2
FOOD ALLERGY
Peter Small, MD
Associate Professor of Medicine
McGill University
Division of Allergy and Immunology
Jewish General Hospital
Educational Objectives:
1. Definition and pathophysiology of food allergy
2. Clinical features
3. Management
Contact Person: Peter Small, MD, Chief, Division of Allergy & Immunology, Tel. 514-340-8222 ext. 25434.

*March 9
MOVING BEYOND GLYCEMIC CONTROL IN DIABETES THERAPY
Peter Assimakopoulos, MD
Assistant Professor of Medicine
McGill University
Staff Member, Division of Endocrinology
Jewish General Hospital
Educational Objectives:
1. Review the evolving therapies of oral anti-hyperglycemic agents, non-insulin injectable, and new insulin analogues used in clinical practice
2. Review the individualization of diabetic therapy as outlined in recent guidelines
3. Understand how recent clinical trials have demonstrated non-glycemic benefits of diabetic therapies
Contact Person: Mark Trifiro, MD, Chief, Division of Endocrinology, Tel. 514-340-8222 ext. 23976.

Medical Grand Rounds cancelled on March 16
PULMONARY GENETICS: MOVING FROM THE LAB TO THE CLINIC
Benjamin Raby, MD, MPH
Leila and Irving Perlmutter Professor of Pediatrics, Harvard Medical School
Chief, Division of Pulmonary Medicine, Boston Children’s Hospital
Director, Pulmonary Genetics Center, Brigham and Women’s Hospital
Educational Objectives:
1. Learn how genetics influence a variety of common and less common respiratory diseases
2. To understand how a basic science genetics lab can impact clinical care in respiratory diseases
Contact Person: Carmela Pepe, MD, Division of Pulmonary Medicine, Tel. 514-340-7900.

*March 23
MARCH IS DVT AWARENESS MONTH ANNUAL GRAND ROUNDS
DURATION OF ANTICOAGULATION FOR VENOUS THROMBOSIS
Marc Rodger MD FRCPC MSc (Epidemiology)
Chair, Department of Medicine, Faculty of Medicine, McGill University
Physician-in-Chief, McGill University Health Center
Harry Webster Thorp Professor of Medicine
Educational Objectives:
1. Understand steps required for a clinical decision rule to be ready for everyday clinical use
2. Apply risk benefit approach to duration of anticoagulation
Contact Person:  Susan Kahn, MD, Division of Internal Medicine, Tel. 514-340-8222 extension 24667.

*March 30
OVERCOMING THERAPEUTIC INERTIA BY IMPLEMENTING DEPRESCRIBING
Justin P. Turner, PhD, MClinPharm, BPharm
Faculty of Medicine, Université de Montréal et Centre de recherche de l’Institut universitaire de gériatrie de Montréal
Senior Advisor, Science Strategy, Canadian Deprescribing Network,
Scientific Director, SaferMedsNL          
Educational Objectives:
1. Reviewing the science and principles of evidence based deprescribing
2. Identifying at least one strategy for implementing deprescribing into your practice
Contact Person: José Morais, MD, Chief, Division of Geriatric Medicine, Tel. 514-340-7501.

*Lunch will be served at 12:10 PM. 

JEWISH GENERAL HOSPITAL
DEPARTMENT OF MEDICINE

MONDAY MEDICAL GRAND ROUNDS
FEBRUARY 2020
12:30 - 1:30 PM
BLOCK AMPHITHEATRE

*February 3
THIRTY FIRST ANNUAL HUMANIZATION OF CARE AWARENESS PROGRAM ROUNDS
MANAGEMENT OF DIFFICULT ENCOUNTERS WITH PATIENTS AND FAMILIES
Robert Biskin, MDCM, FRCPC, MSc
Assistant Professor of Clinical Psychiatry , McGill University
Jewish General Hospital - Institute of Community and Family Psychiatry
Educational Objectives:
At the end of this lecture participants will be able to:
1. Recognize and understand the origins of some challenging clinical challenges
2. Recognize what is a “personality disorder”
3. Review strategies to help with particular types of behaviors
4. Emphasize how to work effectively as a team in difficult situations
Contact Person: Ms. Belinda Amodio, Administration Coordinator, Humanization of Care Committee, Ext. 29124.

*February 10
I. THE HISTORY OF A MISSED DIAGNOSIS
Anthony Lieu, MD
Chief Medical Resident and Internal Medicine Third Year Medical Resident
McGill University and Jewish General Hospital
Educational Objectives:
1. Review the clinical presentation of disseminated histoplasmosis 
2. Review the clinical presentation of negative culture-infective endocarditis
3. Become familiar with the diagnostic testings for disseminated histoplasmosis
II. ATYPICAL HEMOLYTIC UREMIC SYNDROME
Diana Escobar Olaya, MD
Internal Medicine Second Year Resident
McGill University and Jewish General Hospital
Educational Objectives:
1. Quick approach thrombotic microangiopathies, specifically, atypical hemolytic uremic syndrome
2. Clinical presentation/ genetic abnormalities
3. Treatment
Contact Person: Elise Levinoff, MD, Director, Postgraduate Teaching, Tel. 514-340-8222 poste 24974.


*February 17
QUALITY IMPROVEMENT AND THROMBOSIS: A GENERAL INTERNAL MEDICINE SHIDDUCH
Maral Koolian, MD
Assistant Professor of Medicine, McGill University
Division of Internal Medicine, Jewish General Hospital
Blair Schwartz, MDCM, MHS, FRCPC
Assistant Professor, Department of Medicine, McGill University
Division of General Internal Medicine and Department of Adult Critical Care, Jewish General Hospital
& Vicky Tagalakis, MD, FRCPC, MSc
Associate Professor of Medicine
Director, Division of General Internal Medicine
McGill University
Division of Internal Medicine, and Centre for Clinical Epidemiology of the Lady Davis Institute for Medical Research, Jewish General Hospital
Educational Objectives:
1. To review the application of core quality improvement principles to ameliorate quality of care of patients with venous thromboembolic disease
2. To demonstrate the interplay between QI and Thrombosis expertise
3. To present research done at the Jewish General Hospital in General Internal Medicine combining both of these domains 
Contact Person: Rubin Becker, MD, Chief, Division of Internal Medicine, Tel. 514-340-7596.

ºFebruary 24
EXERCISING THE HEART - SOME POSITIVE “STRESS” FOR A CHANGE
Ann Walling, MD
Associate Professor of Medicine, McGill University
Staff Member, Division of Cardiology, Jewish General Hospital
&Lisa Masse, MSc KIN
Kinesiologist
CIUSSS Centre-Ouest Cardiac Rehabilitation Center
Richardson Hospital
Educational Objectives:
1. Provide an overview of cardiac and non cardiac benefits of exercise
2. Review the impact of delay in starting cardiac rehab enrollment
3. Discuss obstacles to successful cardiac rehab
Contact Person: Lawrence Rudski, MD, Chief, Division of Cardiology and Director, Azrieli Heart Center, Tel. 514-340-8222 ext. 22992.

*Lunch will be served at 12:10 PM. 
ºPlease bring your own lunch on February 24, 2020.

The Medical Grand Rounds are an accredited group learning activity as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada.

JEWISH GENERAL HOSPITAL
DEPARTMENT OF MEDICINE
MONDAY MEDICAL GRAND ROUNDS
JANUARY 2020
12:30 - 1:30 PM
BLOCK AMPHITHEATRE

*January 6
ARE THE TOXICITIES OF CANCER IMMUNE CHECKPOINT INHIBITORS ON YOUR CHECKLIST?
Khashayar Esfahani MD, MSc, FRCPC, FACP
Assistant Professor of Oncology 
Rossy Cancer Network, McGill University
Staff Member, St-Mary's Hospital
Researcher, Lady Davis Institute, Jewish General Hospital
Educational Objectives:
1- A brief overview of recent progress in cancer immunotherapy
2- Optimal diagnosis and management of immune-related adverse events
3- Case-based discussion of critical decision making components
Contact Person: Lawrence Panasci, MD, Division of Oncology, Tel. 514-340-8248.

*January 13
BRIDGING THE FACULTY AND CLINICAL "DIVIDES": HOW UGME AND FACULTY DEVELOPMENT WORK TOGETHER TO HELP YOU HELP OUR LEARNERS
Beth-Ann M. Cummings, MD, MSc (Health Professions Education), FRCPC
Associate Dean, Undergraduate Medical Education, Faculty of Medicine
Associate Professor, Department of Medicine
McGill University
Associate Member, Institute of Health Science Education
Division of Internal Medicine, Jewish General Hospital
& Michelle Elizov, MD FRCPC MHPE
Associate Professor of Medicine and Associate Dean, Faculty Development
McGill University
Division of Internal Medicine, Jewish General Hospital
Educational Objectives:

1. To describe educational challenges in DoM from both teacher and learner perspectives

2. To understand how UGME and Faculty Development communicate and collaborate to support teachers

3. To describe best practices in making an educational “diagnosis” and communicating it effectively

Contact Person: Rubin Becker, MD, Chief, Division of Internal Medicine, Tel. 514-340-7596.

ºJanuary 20

BUILDING AN INTERDISCIPLINARY INTER-INSTITUTIONAL RESEARCH INITIATIVE: LESSONS LEARNED FROM MI4

Donald Sheppard, MD, FRCPC
Director, McGill Interdisciplinary Initiative in Infection and Immunity 
Chair, Department of Microbiology & Immunology
Professor, Department of Medicine, Microbiology & Immunology
McGill University
Educational Objectives:
1. To review the mission, structure and vision of the McGill Interdisciplinary Initiative in Infection and Immunity (MI4)
2. To learn to identify barriers to collaborative research and discuss strategies to mitigate these challenges
Contact Person: Karl Weiss, MD, Chief, Division of Infectious Diseases, Tel. 514-340-8222 ext. 28294.

ºJanuary 27
INFLAMMATION REDUCTION IN CARDIOVASCULAR DISEASE

Jean-Claude Tardif CM, MD, FRCPC, FCCS, FACC, FAHA, FESC, FCAHS
Director, MHI Research Center
Professor of medicine
Canada Research Chair in translational and personalized medicine
Université de Montréal endowed research chair in atherosclerosis
Montreal Heart Institute
Educational Objectives:
1. Understand the evidence implicating inflammation in atherosclerosis
2. Learn about the trials that have tested inflammation reduction in coronary disease
Contact Person: Lawrence Rudski, MD, Chief, Division of Cardiology and Director, Azrieli Heart Center, Tel. 514-340-8222 ext. 22992.

*Lunch will be served at 12:10 PM. 
ºPlease bring your own lunch on January 20 & 27.

 

The Medical Grand Rounds are an accredited group learning activity as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada.

HÔPITAL GÉNÉRAL JUIF
DÉPARTEMENT DE MÉDECINE
CONFÉRENCES SCIENTIFIQUES
12H30 - 13H30
SALLE BLOCK AMPHITHÉATRE

 

* Un léger déjeuner sera servi à 12h10.

JEWISH GENERAL HOSPITAL
DEPARTMENT OF MEDICINE
MONDAY MEDICAL GRAND ROUNDS
12:30 - 1:30 PM
BLOCK AMPHITHEATRE

* Lunch will be served at 12:10 PM.

* December 16, 2019

INFLAMMATION AFTER STROKE: A TREATABLE MECHANISM OF COGNITIVE IMPAIRMENT?

Alexander Thiel, MD, PhD

Associate Professor, Department of Neurology and Neurosurgery, McGill University
Director, Comprehensive Stroke Centre, Jewish General Hospital
Director, Neuroplasticity Research Program, Lady Davis Institute for Medical Research

Educational Objectives:

1. To learn the difference between post-stroke cognitive impairment (PSCI) and other forms of age related cognitive decline
2. To learn about the role of neuroinflammation for neurodegeneration after stroke
3. To learn how diabetes and hypertension can modulate brain inflammation
4. To learn about possible treatment strategies

Contact Person: Jeffrey Minuk, MD, Chief, Department of Neurosciences, Tel. 514-340-8222 ext. 28770.

December 9, 2019

NANO-MEDICINE- THE FUTURE IS HERE

Mark Trifiro, MD
Professor of Medicine, McGill University
Chief, Division of Endocrinology, Jewish General Hospital

Educational Objectives:

1. Introduction to nano-particles and role in nano-medicine
2. Treatment of neoplasms in the context of inter tumoral and intra tumoral heterogeneity

Contact Person: Mark Trifiro, MD, Chief, Division of Endocrinology, Tel. 514-340-8222 ext. 23976.

* December 2, 2019

THE JOURNEY OF ENDOVASCULAR TREATMENT IN ACUTE STROKE: WHERE ARE WE COMING FROM, WHERE WE ARE NOW, WHERE WE ARE GOING

Daniel Roy, MD, FRCPC

Professor of Radiology, Université de Montréal
Head of the Neuroradiology Division, CHUM

Educational Objectives:

1. To understand the clinical evidence underlying the 2015 revolution in the treatment of acute stroke
2. To appreciate the controversy regarding the imaging-based patient’s selection for thrombectomy
3. To understand the current issues regarding the expansion of indications as well as the implementation of this treatment

Contact Person: Paul Warshawsky, MD, Chief, Department of Adult Critical Care, Tel. 514-340-7500.

September 2, 2019

Labour Day - No Rounds

September 9, 2019

No rounds

September 16, 2019

CLINICAL ETHICS ROUNDS
ETHICAL ISSUES REGARDING PEG FEEDING TUBES FOR DEMENTIA PATIENTS; A CASE REVIEW

Educational Objectives:
1. Engage in a discussion about the risks and benefits of the intervention 
2. Analyze the role of the patient’s substitute decision-maker regarding feeding tube’s 
3. Review of legal components 
 
Mr. Kevin Hayes
Clinical Ethicist 

Albert Cohen, MD
Associate Professor of Medicine, McGill University 
Chief, Division of Gastroenterology, Jewish General Hospital 

Me Andréane Baribeau
Attorney- CIUSSS West Central Montreal

September 23, 2019

THE FUTURE OF PATHOLOGY: FACTS, TRENDS, AND DREAMS 

Educational Objectives:
At the end of the presentation, the attendees will:
1. Be more familiar with the recent and current evolution of Pathology, especially in the field of molecular pathology and contextual genomics
2. Better understand the current and coming disruptive technologies in Pathology
3. Have some ideas on the mid- and long-term direction of medical diagnostics, including Pathology 
 
Alan Spatz, MD 
Professor of Pathology and Oncology, McGill University 
Director, Division of Pathology, Jewish General Hospital
Canada Research Chair in Molecular Pathology  

September 30, 2019

No Rounds - Rosh Hashanah

* October 7, 2019

FIFTH ANNUAL DEPARTMENT OF MEDICINE CLINICAL RESEARCH SYMPOSIUM
I. AN ASSAY TO MEASURE CYP3A4 AND CYP1A2 ENZYME ACTIVITY IN HUMANS: POTENTIAL RELEVANCE IN LUNG CANCER 
Thomas Jagoe, MD, PhD, FRCP

Associate Professor of Medicine, McGill University
Director, McGill Cancer Nutrition Rehabilitation (CNR) Program
Co-Director of Peter Brojde Lung Cancer Centre (PBLCC)
Staff, Division of Pulmonary Medicine
Jewish General Hospital
Educational Objectives:
1. To remind audience about potential clinical importance of CYP3A4 enzyme activity in drug metabolism
2. To outline the theoretical link between activity of CYP3A4 and CYP1A2 enzymes and metabolism of certain anticancer drugs used in lung cancer
3. To detail the range of different factors which can influence activity of these enzyme
II. A MULTIDISCIPLINARY APPROACH TO DOCUMENTATION OF DELIRIUM IN HOSPITALIZED MEDICAL PATIENTS
Elise Levinoff, MD

Assistant Professor of Medicine, McGill University
Staff, Division of Geriatric Medicine, Jewish General Hospital
Educational Objectives: 
1. To assess whether a focused teaching session on delirium in hospitalized medical inpatients can improve documentation 
2. To determine whether the change in documentation leads to better work up and management of delirium in hospitalized inpatients
3. To promote the importance of AAPA (Approche Adaptée à la Personne Âgée) and its relevance to hospitalized medical patients
III. UNUSUAL HOBBIES AND BAD HABITS: MY EXPERIENCE WITH FECAL MICROBIOTA TRANSPLANT AT THE JGH
Marty Teltscher, MDCM, FRCPC 

Medical Lead, JGH Antimicrobial Stewardship Program
Assistant Professor, McGill University Faculty of Medicine
Division of Infectious Diseases, Department of Microbiology
CIUSSS - CO Montréal - West Central Montreal Health
Jewish General Hospital 
Educational Objectives: 
1. What is fecal microbiota transplant, and why is thought to work? 
2. Is there something particular about patients that suffer from recurrent/refractory C. difficile infections?
3. What I have encountered while doing consults for FMT
Contact Person: E. L. Schiffrin, MD, PhD, Physician-in-Chief, Department of Medicine, Tel. 514-340-7538.

October 14, 2019

No Rounds - Thanksgiving

* October 21, 2019

CLEANLINESS AND GODLINESS: REVISITING SKIN HYGIENE AND CUTANEOUS T CELL DYSREGULATION IN ATOPIC DERMATITIS 
Carolyn Jack, MDCM, PhD, FRCPC

Assistant Professor of Medicine, McGill University
Divisional Lead in Quality and Innovation
Division of Dermatology Medicine
St. Mary's Hospital and Jewish General Hospital
McGill University Health Centre 
Educational Objectives: 
1. What is the role of Staphylococcus Aureus in Atopic Disease ?
2. What kind of cells give us immunity at the skin surface?
3. What is the role of soap in skin health? 
Contact Person: Robin Billick, MD, Chief, Division of Dermatology, Tel. 514-340-8222 ext. 25065.

* October 28, 2019

DILEMMAS IN THE CARE OF THE PERSON WITH ADVANCED DEMENTIA
Susan Mitchell, MD, MPH

Professor of Medicine, Harvard Medical School  
Senior Scientist, Hinda and Arthur Marcus Institute for Aging Research
Director, Palliative Care in Aging Research Center
Co-Director of the Interventional Studies in Aging Center
Hebrew Senior Life in Boston 
Educational Objectives: 
1. Understand the clinical course of advanced dementia
2. Gain knowledge regarding the most common complications and management outcomes in advanced dementia
3. Be able to operationalize an ethically sound, evidence based approach to decision-making in advanced dementia 
Contact Person: José Morais, MD, Chief, Division of Geriatric Medicine, Tel. 514-340-7501.

*November 4

RECENT ADVANCES AND NOVEL APPROACHES IN TARGETED THERAPY FOR LUNG CANCER

Carmela Pepe, MD, FRCPC
Assistant Professor of Medicine, McGill University
Division of Pulmonary Diseases, Department of Medicine, Jewish General Hospital

& Jason Agulnik, MD, FRCPC
Assistant Professor of Medicine, McGill University
Division of Pulmonary Diseases, Department of Medicine, Jewish General Hospital

Educational Objectives:
1. Review recent novel therapies in oncogenic driven lung cancer (Dr. Pepe)
2. Review strategies in detection of molecular targets (Dr. Agulnik)
Contact Person: Carmela Pepe, MD, Division of Pulmonary Medicine, Tel. 514-340-8222 ext. 23636.

*November 11

CANADIAN PATIENT SAFETY WEEK

IMPROVING DISCLOSURE IN PERSON CENTERED CARE

Suzanne Levitz, MD
Associate Director of Professional Services (DPS), CIUSSS CODIM

Mrs. Chantal Bellerose
Assistant to the Directorate of Quality, Innovation, Evaluation, Performance and Clinical Ethics (DQIEPE) Coordinating Quality, Risk Management, Accreditation, Clinical Ethics, User Experience and Planetree, CIUSSS CODIM

Me Nathalie Lecoq
Chief Legal Counsel and Coordinator of Legal Affairs
Directorate of Human Resources, Communications and Legal Affairs (DHRCAJ), CIUSSS CODIM

Ms. Isabelle Caron
Associate Nursing Director, CIUSSS CODIM

Mr. Evan Litwin
Patient Partner

Educational Objectives:
1. Reviewing disclosure obligations and data on our current practice
2. Building our skills towards disclosure and continuously improving our culture of caring, learning, improvement and trust
3. Recognizing challenges in documenting and ensuring effective communication to manage events and meet mandatory AH-223 reporting guidelines
4. Ensuring person centered care and services, team work and user-patient-family partnership for success: closing the loop 

Contact Person: Chantal Bellerose, Dt. P., B. Sc., M. Sc. Health Adm., Assistant to DGA -Director, Director DQEPEA and Coordinator of quality, risk management, accreditation, clinical ethics and user experience, ext. 27895.

*November 18

MULTIPLE MYELOMA: 2019 AND BEYOND

Rayan Kaedbey, MD
Assistant Professor of Medicine, McGill University
Member, Division of Hematology, Jewish General Hospital

Educational Objectives:
1.To recognize the updated diagnostic criteria and prognostication strategies
2. To recognize current treatment approaches
3. To understand future directions in testing and therapeutics
Contact Person: Hans Knecht, MD, Chief, Division of Hematology, Tel 514-340-8222 ext. 28799.

*November 25

CAN WE ELIMINATE HEPATITIS C?

Averell Sherker, MD, FRCPC
Scientific Advisor for Viral Hepatitis and Liver Diseases, Division of Digestive Diseases and Nutrition
Adjunct Investigator, Clinical Research Section, Liver Diseases Branch
National Institute of Diabetes and Digestive and Kidney Diseases
Bethesda, Maryland

Educational Objectives:
1. Understand the epidemiology, natural history, and treatment of Hepatitis C
2. Understand strategies for the eradication of Hepatitis C
3. Become aware of ongoing implementation projects worldwide
Contact Person: Polymnia Galiatsatos, MD, Division of Gastroenterology, Tel. 514-340-8222 x 28144.

2018-2019

September 17, 2018

IT'S NEITHER BENIGN NOR MALIGNANT, IT'S NIFTP: RECENT UPDATES IN THE CLASSIFICATION OF THYROID TUMORS

Marc Philippe Pusztaszeri, MD
Associate Professor of Pathology, McGill University
Staff Member, Department of Pathology 
Jewish General Hospital 

Educational Objectives:
1. To be familiar with the most common types of thyroid neoplasms and the way they are diagnosed
2. To be familiar with the new entity NIFTP
3. To understand the impact of NIFTP on the diagnosis and management of patients with thyroid nodules 
Contact Person:  Alan Spatz, MD, Chief, Department of Pathology, Tel. 514-340-8274.

September 24, 2018

NO MEDICAL ROUNDS - SPECIAL EVENT FOR THE DEPARTMENT OF MEDICINE MEDICAL DOCTORS ONLY

*October 1, 2018

FOURTH ANNUAL DEPARTMENT OF MEDICINE CLINICAL RESEARCH SYMPOSIUM

I. QUALITY IMPROVEMENT AT THE JGH

Blair Schwartz, MDCM, MHS, FRCPC
Assistant Professor, McGill University
Division of General Internal Medicine
Department of Medicine
Department of Adult Critical Care
Jewish General Hospital

Educational Objectives:
1. To explore the nature of quality improvement research 
2. To review findings of QI work at the JGH 

II. EFFECT OF A PCSK9 NEUTRALIZING ANTIBODY ON CD36 DEGRADATION AND HEPATIC STEATOSIS IN A TRANSLATIONAL MOUSE MODEL

Morris Schweitzer PhD, MD, FRCP(C)
Associate Professor, Faculty of Medicine, McGill University
Director, Lipid Research and Management Clinic
Co-Director, Centre for Vascular Prevention
Staff, Division of Endocrinology
Jewish General Hospital

Educational Objectives: 
1. Understand the importance of CD36 in regulating the uptake of fatty acids in the liver
2. Understand the role of PCSK9 in inducing CD36 degradation in the liver
3. Understand how a PCSK9 neutralizing antibody can affect hepatic steatosis in a translational mouse model 

III. INNATE IMMUNE RESPONSE TO VACCINES AND VACCINE ADJUVANTS DELIVERED INTRAMUSCULARLY: DEFINING THE ROLE OF SKELETAL MUSCLE MYOCYTES

Gerasimos J. Zaharatos, MD, FRCPC
Assistant Professor of Medicine, McGill University
Chief, Division of Medical Microbiology
OPTILAB Montreal - MUHC
Division of Infectious Diseases, Jewish General Hospital

Educational Objectives: 
1. Provide an update of innate immune sensing pathways for pathogen-associated molecular patterns including pathogen-derived DNA and RNA
2. Review local immune responses in vaccine and vaccine adjuvant-injected muscle
3. Describe the cytosolic DNA sensing pathway in a skeletal muscle myocyte model 
Contact Person: E. L. Schiffrin, MD, PhD, Physician-in-Chief, Department of Medicine, Tel. 514-340-7538.

October 8, 2018

No Rounds - Thanksgiving

*October 15, 2018

ATOPIC DISEASE

Emma Guttman-Yassky, MD, PhD 
Sol and Clara Kest Professor of Dermatology
Vice Chair for Research, Department of Dermatology 
Director of the Center for Excellence in Eczema
Laboratory of Inflammatory Skin Diseases, Icahn School of Medicine, Mount Sinai Medical Center, New York

Educational Objectives: 
1. Understand immune mechanisms underlying atopic dermatitis
2. Understand the mechanistic basis of the therapeutic developments in atopic dermatitis 
Contact Person: Robin Billick, MD, Chief, Division of Dermatology, Tel. 514-340-8222 ext. 5065.

*October 22, 2018

HOW TO DIE YOUNG AT A VERY OLD AGE

Nir Barzilai, MD
Professor of Medicine, Division of Endocrinology
Director, Institute for Aging Research Albert Einstein College of Medicine
Director, Nathan Shock Center of Excellence in Basic Biology of Aging
Ingeborg and Ira Leon Rennert Chair of Aging Research

Educational Objectives: 
1. Define the role of biology of aging in the onset of age-related diseases
2. Understand that aging can be targeted and prevent a variety of age-related diseases
3. Appreciate the strategy of changing the regulation (FDA etc..) for targeting aging
Contact Person: José Morais, MD, Chief, Division of Geriatric Medicine, Tel. 514-340-7501. 

*October 29, 2018

TELE-PULMONARY REHABILITATION: DOES OFFERING A HEALTHCARE SERVICE VIA TELE-MEDICINE WORK?

Nathalie Saad, MD
Assistant Professor of Medicine
McGill University 
Division of Pulmonary Medicine
Jewish General Hospital

Educational Objectives: 
1. To understand how tele-pulmonary rehabilitation improves accessibility to services 
2. To understand the impact of the tele-pulmonary rehabilitation program on patient’s health
3. To discuss the barriers to the development of a tele-medicine program in Quebec 
Contact Person: Carmela Pepe, MD, Division of Pulmonary Medicine, Tel. 514-340-8222 ext. 23636. 

*November 5, 2018

CANADIAN PATIENT SAFETY WEEK
MEDICATION MANAGEMENT AND PATIENT SAFETY: WHAT YOU NEED TO KNOW

Eva Cohen: B. Pharm., D.P.H.
Director of Pharmacy
Ryan Kerzner, B. Pharm., M. Sc.
Pharmacist
& Gaelle Abittan B. Pharm., M. Sc.
Assistant Director of Pharmacy

Educational Objectives: 
1. Review Medication Management Accreditation Standards
2. JASPRO: Role of Antimicrobial Stewardship Program
3. Understand clinical pertinence of medication reconciliation and strategies currently in place to achieve standards
Contact Person: Chantal Bellerose,  Dt. P., B. Sc., M. Sc. Health Adm., Assistant to DGA -Director, Director DQEPEA and Coordinator of quality, risk management, accreditation, clinical ethics and user experience, ext. 27895. 

*November 12, 2018

MYELOPROLIFERATIVE NEOPLASM: 2018 UPDATE ON DIAGNOSIS AND MANAGEMENT

Shireen Sirhan, MD
Assistant Professor of Medicine
McGill University
Member, Division of Hematology
Jewish General Hospital

Educational Objectives:
1. 2016 WHO revision of MPN diagnostic criteria and its practical implications 
2. Diagnostic algorithms for Essential Thrombocytosis and Polycythemia Vera 
3. Overview of Current and future Therapies 
4. Overview of Practical Management issues with new therapies 
Contact Person: Hans Knecht, MD, Chief, Division of Hematology, Tel 514-340-8222 ext. 28799.

*November 19, 2018

THE ROLE OF PSYCHOSOCIAL DETERMINANTS IN QUALITY OF LIFE (QoL) IN INFLAMMATORY BOWEL DISEASE - MOVING TOWARDS A POSITIVE PARADIGM

Gary E. Wild, MDCM, PhD, M. Sc. (Health Psychology), FRCPC
Grad. Cert. Health and Social Services
Division of Gastroenterology
McGill University Health Centre 

Educational Objectives: 
1. To gain an understanding of the determinants of QoL in adult IBD patients.
2. To gain an understanding of the cognitive and affective domains of the IBD illness experience
3. To gain an understanding of the applications of Positive Psychology as a tool to improve well- being in IBD 
Contact Person: Polymnia Galiatsatos, MD, Division of Gastroenterology, Tel. 514-340-8222 x 28144.

*November 26, 2018

WHAT'S METABOLIC SYNDROME

Mark Trifiro, MD
Professor of Medicine, McGill University 
Chief, Division of Endocrinology, Jewish General Hospital
Educational Objectives: 
1. Etiology of metabolic syndrome
2. Consequences and impact of metabolic syndrome 
Contact Person: Mark Trifiro, MD, Chief, Division of Endocrinology, Tel. 514-340-8222 ext. 23976.

*December 3, 2018

EXTRACORPOREAL CARDIOPULMONARY RESUSCITATION (E-CPR) IN 2018: HOW, WHEN AND WHOM?

Martin Albert, MD, FRCPC, FACP
Internist-Intensivist, Hôpital du Sacré-Coeur de Montréal
Director of Intensive Care Program, University of Montreal
Clinical Professor, University of Montreal
Regular Researcher, HSCM Research Center
Intensivist, Montreal Heart Institute

Educational Objectives: 
1. Become aware of the growing use of extracorporeal cardiopulmonary resuscitation (E-CPR) for resuscitation in specific settings
2. Understand the basic principles of E-CPR
3. Identify patients who may be candidates for E-CPR
Contact Person: Paul Warshawsky, MD, Chief, Department of Adult Critical Care, Tel 514-340-7500.

*December 10, 2018

CROSSROADS BETWEEN MOOD SYMPTOMS AND AUTONOMIC DISTURBANCES IN ALPHA-SYNUCLEINOPATHIES

Chenjie Xia, MDCM, FRCPC 
Assistant Professor of Neurology and Neurosurgery
McGill University 
Neurologist
Jewish General Hospital 

Educational Objectives: 
1. Review mood symptoms and autonomic disturbances in alpha-synucleinopathies 
2. Discuss how the link between them may shed light on pathophysiology of mood disorders 
Contact Person: Jeffrey Minuk, MD, Chief, Department of Neurosciences, Tel. 514-340-8222 ext. 28770.

*December 17, 2018

UPDATE ON METASTATIC PROSTATE CANCER

Cristiano Ferrario, MD
Assistant Professor of Medicine, McGill University
Member, Division of Hemato-Oncology
Jewish General Hospital 

Educational Objectives: 
1. Review of current diagnosis of metastatic prostate cancer
2. Review of safety and efficacy of multiple treatment options currently available for metastatic prostate cancer 
Contact Person: Lawrence Panasci, MD, Division of Hemato-Oncology, Tel. 514-340-8248.

*January 7, 2019

POLYGENIC RISK SCORES TO PREDICT CLINICAL OUTCOMES

Brent Richards, MD
Professor of Medicine, McGill University 
Staff Member, Division of Endocrinology, Jewish General Hospital

Educational Objectives: 
1. To understand how genotypes from birth can be used to predict clinical outcomes later in life
2. To understand how to interpret a genetic risk prediction 
Contact Person: Mark Trifiro, MD, Chief, Division of Endocrinology, Tel. 514-340-8222 ext. 23976.

ºJanuary 14, 2019

Time to move on – from 9H to 4R: shorteR, safeR, cheapeR and betteR
Results of two randomized trials in adults and children, of 4 months Rifampin (4R) vs 9 months Isoniazid (9H) for treatment of latent TB

Richard Menzies, MD
Professor of Medicine, of Epidemiology and of Biostatistics , McGill University 
Associate Director of the McGill International TB Centre 
Member, Respiratory Division, MUHC Department of Medicine 

Educational Objectives:
1. To understand the potential risks and benefits of treatment of latent tuberculosis infection (LTBI)
2. To understand the potential advantages and disadvantages of different regimens for treatment of LTBI – in particular the current standard of 9 months INH (9H), and the new regimen of 4 months rifampin (4R) 
Contact Person: Karl Weiss, MD, Chief, Division of Infectious Diseases, Tel. 514-340-8222 ext. 22933.

*January 21, 2019

AN EPIDEMIOLOGICAL ANALYSIS OF THE MEDICAL LITERATURE: LESSONS LEARNED FROM AN ACCIDENTAL CAREER IN MEDICAL JOURNALISM

Christopher Labos, MDCM, MSc
Associate member, Office for Science and Society McGill University 
Contributor for the Montreal Gazette and CJAD 

Educational Objectives: 
1. To understand how issues of study design and analysis can affect the outcomes of clinical studies
2. To review how issues like confounding, bias, reverse causation, and random error lead us to misinterpret the findings of medical studies
3. To explore the common mistakes we make as both producers and consumers of scientific news 
Contact Person: Lawrence Rudski, MD, Chief, Division of Cardiology and Director, Azrieli Heart Center, Tel. 514-340-8222 ext. 22992.

*January 28, 2019

THIRTIETH ANNUAL HUMANIZATION OF CARE AWARENESS PROGRAM ROUNDS
KEEPING IT TOGETHER WHEN EVERYONE AROUND YOU IS FALLING APART
 

Susan Wener
Author, Therapist, Educator 

Educational Objectives: 
At the end of this lecture participants will be able to:
1. Understanding the importance of taking care of yourself while taking care of others
2. Learning to better use the resources available to you and within you
3. Understanding the patient-doctor and multidisciplinary team dynamic as a partnership
Contact Person: Ms. Rosamary Steinberg, Co-Chair, Humanization of Care Committee, Tel. 514-340-8222 ext. 25833.

*February 4, 2019

FOURTH ANNUAL MCGILL GLOBAL HEALTH INITIATIVE IN HAITI LECTURESHIP
AN IMPACTFUL AND LONGITUDINAL EXPERIENCE

Tanya Girard, MD
Internal Medicine Third Year Resident
McGill University & Montreal General Hospital  
Moneeza Walji, MD
Hematology Fourth Year Resident
All Three Sites, McGill University
Educational Objectives:
1. To present the history of Zanmi Lasante (Partners in Health) and Haiti
2. To share the history and goals of McGill's Global Health Initiative in Haiti
3. To present highlights of the 2017 and 2018 groups' experiences
4. To discuss clinical cases encountered
Contact Person: Ruxandra Bunea, MD, Director, Postgraduate Teaching, Tel. 514-340-8222 poste 24974.

*February 11, 2019

CANCER ASSOCIATED VENOUS THROMBOEMBOLISM: NEW ANTICOAGULANT THERAPEUTICS
Vicky Tagalakis, MD, FRCPC, MSc

Associate Professor of Medicine
McGill University 
Division of Internal Medicine and 
Centre for Clinical Epidemiology of the Lady Davis Institute for Medical Research
Jewish General Hospital 
Educational Objectives:
1. To understand the importance of anticoagulant therapy in cancer associated thrombosis
2. To learn of the latest evidence for direct oral anticoagulants in the treatment of cancer associated thrombosis
3. To position the new and older anticoagulants in the individualized approach to the management of cancer associated thrombosis 
Contact Person: Rubin Becker, MD, Chief, Division of Internal Medicine, Tel. 514-340-7596. 

*February 18, 2019

THROMBOTIC MICROANGIOPATHY (TMA) – IMPORTANCE OF THE DIFFERENTIAL DIAGNOSIS… HOW CLASSIFICATION IMPACTS INVESTIGATIONS AND MANAGEMENT
Louis-Philippe Girard, MD, MBT, FRCPC 

Clinical Associate Professor of Medicine and Nephrologist, University of Calgary 
Educational Objectives: 
1. To discuss the pathophysiology of different TMAs, including evolving concepts in the science and role of complement
2. To discuss the differential diagnosis of conditions leading to TMAs
3. To discuss the investigations required to evaluate a patient with TMA
4. To discuss directed therapy based on the underlying cause of the TMA
Contact Person: Mark Lipman, MD, Chief, Division of Nephrology, Tel. 514-340-8229.

*February 25, 2019

KETOGENIC DIET AND DIABETES: WHY THE RESISTANCE?
Elizabeth MacNamara, MD

Associate Professor of Medicine, McGill University
Chief, Division of Medical Biochemistry, Jewish General Hospital
& Shaun Eintracht, MD, FRCPC
Assistant Professor of Medicine
McGill University 
Division of Medical Biochemistry
Jewish General Hospital
JGH Medical Biochemistry Site Director Optilab 
Educational Objectives: 
1. Understand the basic biochemistry about the diet
2. Understand why it works
3. Understand the controversy and resistance to it
Contact Person: Elizabeth MacNamara, MD, Chief, Division of Medical Biochemistry, Tel. 514-340-8222 x 25091.

*March 4, 2019

OPTIMUM DIET FOR A LONG & USEFUL LIFE: WHAT’S THE EVIDENCE? 
L. John Hoffer, MD, PhD, FRCPC 

Professor of Medicine, McGill University 
Member, Division of Internal Medicine and Nutrition Support Team, Jewish General Hospital 
Educational Objectives: 
1. Help learners penetrate the fog of hope and hype surrounding longevity diets, using the searchlight of nutritional physiology and scientific reasoning
2. Help learners balance biological plausibility, clinical evidence, unavoidable uncertainty and the rules of evidence-based medicine to formulate recommendations tailored to the situation, interests and preferences of individual patients
Contact Person: Rubin Becker, MD, Chief, Division of Internal Medicine, Tel. 514-340-7596.

*March 11, 2019

EMERGENCY ROOM AND OLDER PATIENTS: TO BE FRAIL OR AT RISK?
Olivier Beauchet, MD, PhD, FRCPC
 
Professor of Medicine & Dr. Joseph Kaufmann Chair in Geriatric Medicine
Director of Centre of Excellence on Longevity
McGill University     
Staff, Division of Geriatric Medicine
Clinical Scientist, Department of Medicine, Division of Geriatric Medicine
Jewish General Hospital & Lady Davis Institute for Medical research 
Visiting Professor, Lee Kong Chian School of Medicine
Nanyang Technological University, Singapore 
Educational Objectives: 
After attending, participants will be able:
1. To understand the issues and challenges related to Emergency Room visits for older patients 
2. To know new validated practices for older patients visiting Emergency Room 
3. To evaluate and propose appropriate care for older patients visiting Emergency Room
Contact Person: José Morais, MD, Chief, Division of Geriatric Medicine, Tel. 514-340-7501.

*March 18, 2019

UNCOMMON MECHANISMS IN THROMBOSIS…RESEARCH THAT COULD CHANGE YOUR PRACTICE
Ed Conway, MD, PhD, MBA 

Professor, Department of Medicine
University of British Columbia
Director, Centre for Blood Research
Canada Research Chair in Endothelial Cell Biology
CSL-Behring Research Chair
Staff Physician, Division of Hematology
Department of Medicine, Vancouver Costal Health
Educational Objectives:
1. Understanding complement-mediated thrombosis
2. Reviewing new data related to mechanisms underlying thrombosis in obesity and cancer
3. Discussing how the research may translate into clinical practice 
Contact Person: Susan Kahn, MD, Division of Internal Medicine, Tel. 514-340-8222 extension 24667.

*March 25, 2019

NEW DRUGS FOR THE TREATMENT OF SEVERE ASTHMA 
Pierre Ernst, MD, MSc, FRCPC 

Professor of Medicine, McGill University 
Member, Division of Pulmonary 
Jewish General Hospital 
Educational Objectives: 
1. To be able to identify patients with truly severe asthma
2. To become familiar with the newer biological agents for severe asthma and when they should be used 
Contact Person: Carmela Pepe, MD, Division of Pulmonary Medicine, Tel. 514-340-7900. 

*April 1st, 2019

LUMPS, BUMPS AND GENES
William D. Foulkes, MD, PhD

James McGill Professor
Departments of Medicine, Human Genetics & Oncology    
McGill Program in Cancer Genetics 
McGill University
Department of Medical Genetics
Jewish General Hospital
Maria Apellaniz-Ruiz, PhD 
Post-Doctoral Fellow, Department of Human Genetics
McGill University
Lady Davis Institute for Medical Research 
Barbara Rivera PhD 
Assistant Professor, Department of Oncology
McGill University 
Educational Objectives: 
1. To summarize the pathways that underlie microRNA biogenesis
2. To articulate how errors in micro RNA biogenesis leads to hyperplastic, benign and malignant tumors of the thyroid, liver and kidney
3. To appreciate an unexpected connection between disorders of both Schwann cells and thyroid cells
Contact Person: David Rosenblatt, MD, Division of Medical Genetics, Department of Medicine and Department of Medical Genetics, Tel. 514-934-1934 x 42978.

*April 8, 2019

MODERN MANAGEMENT OF CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION: JGH’S COMPREHENSIVE INTEGRATED PROGRAM - FROM BENCH TO BEDSIDE TO OPERATING ROOM OR TO CATH LAB
David Langleben, MD

Professor of Medicine, McGill University
Director, Center for Pulmonary Vascular Disease
Cardiologist, Jewish General Hospital 
Andrew Hirsch, MD
Associate Professor of Medicine, McGill University
Director, Division of Pulmonary Medicine, Jewish General Hospital
Jean-François Morin, MD
Associate Professor of Surgery, McGill University
Chief, Cardiac Surgery, Jewish General Hospital
Ali Abualsaud, MD 
Assistant Professor of Medicine, McGill University
Interventional and Structural Cardiologist, Jewish General Hospital 
Educational Objectives:
Understand the pathophysiology of chronic thromboembolic disease
Contact Person: Lawrence Rudski, MD, Chief, Division of Cardiology and Director, Azrieli Heart Center, Tel. 514-340-8222 ext. 22992.

*April 15, 2019

PENICILLIN ALLERGY
Jesse Schwartz, MD

Assistant Professor of Medicine
McGill University
Division of Allergy and Immunology
Jewish General Hospital
Educational Objectives:
Answer to the following questions:
1. How many patients with a label of penicillin allergy are actually allergic?
2. How do we remove an incorrect label of penicillin allergy?
3. Can I give cephalosporins and carbapenems to patients with a label of penicillin allergy?
Contact Person: Peter Small, MD, Chief, Division of Allergy & Immunology, Tel. 514-340-8222 ext. 25434.

April 22, 2019

No Rounds - Easter Monday

*April 29, 2019

2018 LOUIS AND ARTUR LUCIAN AWARD FOR RESEARCH IN CIRCULATORY DISEASES RECIPIENT' S PRESENTATION
UNDERSTANDING AND MANAGING VARIABLE DRUG ACTIONS: FROM THE ECG TO POPULATION GENOMICS (CHAPTER 2: THE CARDIAC CHANNEL) 
Dan M. Roden, M.D.C.M. 

Co-Recipient, 2018 Louis and Artur Luican Award
Professor of Medicine, Pharmacology and Biomedical Informatics 
Senior Vice President for Personalized Medicine
Vanderbilt University Medical Center 
Educational Objectives:
1. To describe the role of normal and abnormal cardiac sodium channel function in human disease
2. To describe new methods to quantify the role of genetic variation in sodium channel function
3. To describe how electronic health records may be used to improve the safety of drug therapy
Contact Person: E. L. Schiffrin, C.M., MD, PhD, Physician-in-Chief, Department of Medicine, Tel. 514-340-7538.

*May 6, 2019

CARDIAC AMYLOIDOSIS: THE MYSTERY “UNFOLDS”
Michael Chetrit MD, FRCPC 

Advanced Cardiac Imaging, Heart and Vascular Institute 
Cleveland Clinic, Ohio 
Educational Objectives:
1. New methods for the diagnosis of cardiac amyloidosis
2. The utility of multimodality imaging in the diagnosis and management.
3. Latest developments in the treatment of cardiac amyloidosis 
Contact Person: Lawrence Rudski, MD, Chief, Division of Cardiology and Director, Azrieli Heart Center, Tel. 514-340-8222 ext. 22992.

*May 13, 2019

AUTOIMMUNE INFLAMMATORY MYOPATHIES: HOW EXTRA MUSCULAR FEATURES ARE STEALING THE SHOW
Valerie Leclair, MD 

Assistant Professor of Medicine, McGill University 
Staff, Division of Rheumatology, Jewish General Hospital 
Educational Objectives:
1. Understand the strengths and weaknesses of the current classification criteria for autoimmune inflammatory myopathies (AIM)
2. Describe different extra muscular features of AIM and their impact on clinical management.
3. Discuss the role of biological treatment in AIM 
Contact Person: Murray Baron, MD, Chief, Division of Rheumatology, Tel. 514-340-8231. 

May 20, 2019

No Rounds - Victoria Day

*May 27, 2019

2018 LOUIS AND ARTUR LUCIAN AWARD FOR RESEARCH IN CIRCULATORY DISEASES RECIPIENT' S PRESENTATION
FROM SECRETORY PRECURSOR PROTEINS TO THE DISCOVERY OF THE FAMILY OF PROPROTEIN CONVERTASES AND THEIR CLINICAL APPLICATIONS 
Nabil G. Seidah, PhD 

Co-Recipient, 2018 Louis and Artur Lucian Award
Professor of Biochemistry, Department of Medicine, University of Montreal 
Director of the Laboratory of Biochemical Neuroendocrinology, Institut de Recherches Cliniques de Montréal (lRCM)
Educational Objectives: 
1. How are bioactive secretory proteins and peptides generated in cells and tissues?
2. Which proprotein convertase(s) are presently targeted for clinical applications and what is the outcome of some of these treatments?
3. What happens when the level/activity of some proprotein convertases is deregulated? 
Contact Person: E. L. Schiffrin, C.M., MD, PhD, Physician-in-Chief, Department of Medicine, Tel. 514-340-7538.

June 3, 2019

THE WORK-UP AND TREATMENT OF CANCER OF UNKNOWN PRIMARY
Lawrence Panasci, MD

Professor of Medicine & Oncology, McGill University 
Associate Director of Oncology, Jewish General Hospital 
Educational Objectives: 
1. How to work-up the unknown primary malignancy
2. How to treat it 
Contact Person: Lawrence Panasci, MD, Division of Hemato-Oncology, Tel. 514-340-8248.

June 10 2019

EVOLVING PARADIGMS IN THE CLINICAL CARE AND TREATMENT OF HEMOGLOBINOPATHIES
Véronique Naessens, MD, FRCPC

Assistant Professor of Medicine, McGill University 
Division of Hematology, McGill University Health Centre 
Educational Objectives: 
1. Recognize the spectrum of acute and chronic complications of sickle cell disease and its current therapies
2. Review the clinical presentations and complications found in severe thalassemic syndromes, including thalassemia intermedia and major
3. Explore the future treatment options in beta-chain hemoglobinopathies 
Contact Person: Hans Knecht, MD, Chief, Division of Hematology, Tel 514-340-8222 ext. 28799.

Page last updated on 

We always seek feedback to make our site better.